LUJEGFRA Trademark

Trademark Overview


On Friday, June 19, 2015, a trademark application was filed for LUJEGFRA with the United States Patent and Trademark Office. The USPTO has given the LUJEGFRA trademark a serial number of 79171509. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 26, 2022. This trademark is owned by NOVARTIS AG. The LUJEGFRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders and diabetes; antifungal, anti-...
lujegfra

General Information


Serial Number79171509
Word MarkLUJEGFRA
Filing DateFriday, June 19, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 26, 2022
Registration Number4896923
Registration DateTuesday, February 9, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders and diabetes; antifungal, anti-infective and antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Saturday, June 17, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Friday, May 26, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, May 26, 2023INVALIDATION PROCESSED
Wednesday, April 26, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 26, 2022CANCELLED SECTION 71
Tuesday, February 9, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, May 27, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 11, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 11, 2016FINAL DISPOSITION PROCESSED
Monday, May 9, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 9, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, November 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2015PUBLISHED FOR OPPOSITION
Friday, November 20, 2015NOTIFICATION PROCESSED BY IB
Wednesday, November 4, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 4, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 21, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 21, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 14, 2015ASSIGNED TO LIE
Friday, October 2, 2015REFUSAL PROCESSED BY IB
Wednesday, September 23, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 16, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 16, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 11, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 11, 2015REFUSAL PROCESSED BY MPU
Friday, September 11, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 10, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 8, 2015ASSIGNED TO EXAMINER
Tuesday, September 8, 2015APPLICATION FILING RECEIPT MAILED
Thursday, September 3, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 28, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 27, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB